MENU
INBX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Inhibrx Biosciences (INBX) Ownership - Who owns Inhibrx Biosciences?
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms... Show more
Profile
Industry
N/A
Address
11025 N. Torrey Pines Road
Phone
+1 858 795-4220
Employees
172
Web
https://www.inhibrx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
176.03M
P/E Ratio
0.11
Total Cash
196.33M
Projected Growth
N/A
Total Debt
1.84M
Revenue
1.57M
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
13.56
Total Debt/Equity
N/A
Revenue/Share
0.01 USD as % of share price
Fundamentals
INBX
Capitalization
176M
P/E Ratio
0.11
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
196M
Total Cash/Share
13.56
Total Debt
1.84M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.01%
Revenue
1.57M
ROE
N/A
Book Value
178M
P/B Ratio
1.32
Cash Flow
N/A
Earnings
119.39
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1K
Current Ratio
4.70
Current Revenue Per Employee
9500.00
Dividends Per Share - Security
N/A
EBITDA
1.72B
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
776.52
Shares Held By Institutions
197M
Shares Outstanding - Current
14.5M
Total Liabilities
44.1M
Total Volume MTD
N/A
Value
-1
Gain YTD
-21.039
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a company, which engages in researching and developing biotechnology
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
11025 N. Torrey Pines Road
Phone
+1 858 795-4220
Employees
172
Web
https://www.inhibrx.com